GlassScriptPhysician profile
Arpan Arun Patel
NPI 1124313820
$2,109.96
in general payments reported to CMS, 2019-2025
10 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $125 · 2022: $323 · 2023: $1,107 · 2024: $244 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Charitable Contribution: $1,000 · Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Charitable Contribution | $1,000.00 |
| Food and Beverage | $545.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,000.00 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $287.33 | 2022-2025 | Xifaxan |
| Madrigal Pharmaceuticals | $199.40 | 2024-2025 | Resmetirom, Rezdiffra |
| Boston Scientific Corporation | $161.02 | 2022 | |
| Abbvie INC. | $125.00 | 2020 | |
| Shire North American Group INC | $115.80 | 2019 | |
| Gilead Sciences, INC. | $107.03 | 2023 | Vemlidy |
| Medtronic, INC. | $65.43 | 2024 | Nexpowder |
| Novo Nordisk INC | $48.95 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.